Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Morphological analysis of mitochondria for evaluating the toxicity of α-synuclein in transgenic mice and isolated
Ge Gao1, Zhipeng Wang1, Lingling Lu1
1Department of Neurobiology, Capital Medical University, Center of Parkinson Disease Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing, 100069, China.
Abstract:
A key molecular event in the pathogenesis of Parkinson's disease is mitochondrial damage caused by α-synuclein (α-syn). Mitochondria mediates both necrosis and apoptosis, which are associated with morphological changes. However, the mechanism by which α-syn alters mitochondrial morphology remains unclear. To address this issue, we investigated mitochondrial permeability transition pore (mPTP) opening and changes in cardiolipin (CL) levels in mitochondria isolated from the brain of Thy1α-syn mice. Cytoplasmic cytochrome C and cleaved caspase-3 protein levels were upregulated in the brain of transgenic mice. Morphological analysis by atomic force microscopy (AFM) suggested a correlation between mitochondrial morphology and function in these animals. Incubation of isolated mitochondria with recombinant human α-synuclein N terminus (α-syn/N) decreased mitochondrial CL content. An AFM analysis showed that α-syn/N induced mitochondrial swelling and the formation of pore-like structures, which was associated with decreased mitochondrial transmembrane potential and complex I activity. The observed mitochondrial dysfunction was abrogated by treatment with the mPTP inhibitor cyclosporin A, although there was no recovery of CL content. These results provide insight into the mechanism by which α-syn/N directly undermines mitochondrial structure and function via modulation of mPTP opening and CL levels, and suggests that morphological analysis of isolated mitochondria by AFM is a useful approach for evaluating mitochondrial injury.
Insights
Alpha-synuclein (α-syn) causes mitochondrial damage in Parkinson's disease. This study reveals α-syn directly alters mitochondrial morphology and function by affecting the mitochondrial permeability transition pore (mPTP) and cardiolipin levels.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial damage is a key factor in Parkinson's disease pathogenesis.
- Alpha-synuclein (α-syn) is implicated in this damage, but the mechanism altering mitochondrial morphology is unclear.
Purpose of the Study:
- Investigate how α-syn affects mitochondrial morphology and function.
- Examine the role of mitochondrial permeability transition pore (mPTP) opening and cardiolipin (CL) levels in α-syn-induced mitochondrial dysfunction.
Main Methods:
- Isolated mitochondria from Thy1-α-syn transgenic mice.
- Atomic force microscopy (AFM) for morphological analysis.
- Biochemical assays for cytochrome C, caspase-3, CL levels, mitochondrial membrane potential, and complex I activity.
- Treatment with mPTP inhibitor cyclosporin A.
Main Results:
- Transgenic mice showed increased cytoplasmic cytochrome C and cleaved caspase-3.
- AFM revealed correlations between mitochondrial morphology and function.
- Recombinant α-syn N-terminus (α-syn/N) reduced CL content, induced mitochondrial swelling, and pore formation.
- α-syn/N decreased mitochondrial membrane potential and complex I activity.
- Cyclosporin A abrogated dysfunction but not CL reduction.
Conclusions:
- α-syn/N directly impairs mitochondrial structure and function by modulating mPTP opening and CL levels.
- AFM is a valuable tool for assessing mitochondrial injury in neurodegenerative diseases.

